Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;36(3):201-7.
doi: 10.1159/000341653. Epub 2012 Aug 17.

Seasonal maintenance of influenza vaccine-induced antibody response in kidney transplant recipients

Affiliations

Seasonal maintenance of influenza vaccine-induced antibody response in kidney transplant recipients

Kelly A Birdwell et al. Am J Nephrol. 2012.

Abstract

Background/aims: Although annual influenza vaccination is recommended for kidney transplant recipients, efficacy as reflected by serum antibody titers has not been well studied beyond 1 month in kidney transplant recipients.

Methods: We performed a single-center prospective cohort study of 51 kidney transplant recipients and 102 healthy controls receiving the 2006-2007 influenza vaccine. Anti-hemagglutinin antibody titers to A/H1N1, A/H3N2, and B were measured before and 1 month after vaccination, and again at the end of influenza season. The primary outcome was the proportion of participants maintaining seroprotection (antibody titer ≥1:32) for the duration of the influenza season after influenza vaccination.

Results: Median follow-up time was 175 and 155 days in the transplant and control groups, respectively. For types A/H1N1 and B, a similar high proportion of the transplant and control groups (88.5 and 81.6% vs. 83.7 and 74.2% for A/H1N1 and B, respectively) maintained seroprotection. For type A/H3N2, significantly less of the transplant group (66.7%) versus the control group (90%) maintained a protective influenza vaccine response (odds ratio 0.21, 95% confidence interval 0.07-0.64). This difference disappeared in adjusted analyses. Actual geometric mean titers decreased significantly within both groups (p < 0.001) but this did not differ between groups.

Conclusions: Once they have developed protective vaccine-induced antibody responses to influenza vaccine, kidney transplant recipients are able to maintain adequate protective levels of antibody compared with healthy controls.

PubMed Disclaimer

Conflict of interest statement

Financial Conflicts of Interest: None of the authors report any conflicts of interest.

Kelly A. Birdwell, MD, MSCI: None

Mine R. Ikizler, MS: None

Edith C. Sannella, MT: None

Li Wang, MS: None

Daniel W. Byrne, MS: None

Peter F. Wright, MD: None

T. Alp Ikizler, MD: None

Figures

Figure 1
Figure 1
Study enrollment and follow up.
Figure 2
Figure 2
Serologic response to the 2006–07 inactivated influenza vaccine expressed as geometric mean titers for the 123 participants. For control group: A/H1N1 pre 35.8, post 113.7, end 60.1; A/H3N2 pre 41, post 210.9, end 78.1; B pre 41.5, post 150.4, end 69.7. For transplant group: A/H1N1 pre 39.2, post 68.1, end 44; A/H3N2 pre 22, post 49.2, end 26.8; B pre 39.2, post 87.5, end 45.7.

Similar articles

Cited by

References

    1. Kotton CN, Fishman JA. Viral infection in the renal transplant recipient. J Am Soc Nephrol. 2005;16:1758–1774. - PubMed
    1. Danzinger-Isakov L, Kumar D. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant. 2009;9 (Suppl 4):S258–262. - PubMed
    1. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, Cox NJ. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010;59:1–62. - PubMed
    1. Vilchez RA, Fung J, Kusne S. The pathogenesis and management of influenza virus infection in organ transplant recipients. Transpl Infect Dis. 2002;4:177–182. - PubMed
    1. Edwards KM, Dupont WD, Westrich MK, Plummer WD, Jr, Palmer PS, Wright PF. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis. 1994;169:68–76. - PubMed

Publication types

MeSH terms

Substances